How long should I wait to initiate aspirin after discontinuing Eliquis (apixaban)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Long to Wait Before Starting Aspirin After Stopping Eliquis

You can start aspirin immediately after stopping Eliquis (apixaban) without any waiting period, as there is no clinically significant drug interaction or additive bleeding risk that requires a washout interval.

Rationale Based on Pharmacology and Guidelines

The timing of aspirin initiation after discontinuing apixaban is fundamentally different from the reverse scenario (stopping antiplatelet agents before procedures). Here's why:

Pharmacokinetic Considerations

Apixaban has a half-life of approximately 12 hours, meaning it is largely eliminated from the body within 48-72 hours after the last dose 1. However, aspirin can be started immediately because:

  • Aspirin works through a completely different mechanism (irreversible COX-1 inhibition) than apixaban (Factor Xa inhibition)
  • There is no pharmacokinetic interaction between these drugs
  • The clinical concern is about thrombotic risk from stopping anticoagulation, not about drug overlap

Clinical Context Matters

The appropriate timing depends entirely on why you're making this switch:

If switching for long-term management (e.g., patient no longer needs full anticoagulation but requires antiplatelet therapy):

  • Start aspirin when you stop apixaban—no gap needed 1
  • The FDA label for Eliquis explicitly states: "Discontinue the anticoagulant other than warfarin and begin taking ELIQUIS at the usual time of the next dose" when switching between anticoagulants, supporting immediate transitions 1

If stopping for a procedure:

  • Eliquis should be stopped 48 hours before low-risk procedures or 72+ hours before high-risk procedures 2, 3, 4
  • Aspirin can be restarted 24-48 hours post-procedure for low bleeding risk, or 48-72 hours for high bleeding risk 2, 3, 4
  • The timing here is dictated by procedural bleeding risk, not drug interaction

Important Clinical Scenarios

For patients with coronary stents or acute coronary syndrome:

  • If a patient was on dual therapy (Eliquis + aspirin) and you're discontinuing Eliquis, continue aspirin without interruption 5
  • The thrombotic risk from stopping aspirin in these patients far outweighs any theoretical concern about overlap 3

For atrial fibrillation patients switching to aspirin:

  • This represents a significant downgrade in stroke prevention
  • Start aspirin immediately when stopping Eliquis to minimize the period without any antithrombotic coverage
  • Be aware that aspirin provides substantially less stroke protection than apixaban in AF patients 1

Key Pitfalls to Avoid

  1. Don't create an anticoagulation gap: The most dangerous scenario is leaving a high-risk patient without any antithrombotic therapy. If switching from Eliquis to aspirin is clinically appropriate, start aspirin immediately 1

  2. Reconsider if the switch is appropriate: Aspirin is dramatically less effective than apixaban for stroke prevention in atrial fibrillation (1.27% vs 3.63% annual stroke rate in AVERROES trial) 1. Make sure downgrading to aspirin is clinically justified.

  3. For procedures requiring Eliquis interruption: The timing of aspirin restart is based on achieving hemostasis (24-72 hours post-procedure depending on bleeding risk), not on waiting for Eliquis clearance 3, 4

  4. Bleeding risk is not additive in the way you might think: While both drugs increase bleeding risk independently, the brief overlap during transition (if any residual apixaban remains) is not clinically significant enough to warrant a waiting period in most situations 6

Practical Algorithm

Step 1: Determine why you're stopping Eliquis

  • Procedure → Follow procedural guidelines for restart timing 3, 4
  • Switching to aspirin for long-term management → Start aspirin immediately

Step 2: Assess thrombotic risk

  • High risk (recent ACS, coronary stents, recent stroke) → No gap in coverage
  • Lower risk → Can start aspirin same day as stopping Eliquis

Step 3: Monitor for bleeding

  • Counsel patient about increased bleeding risk with any antithrombotic
  • Consider GI prophylaxis with PPI if indicated 7

The bottom line: There is no mandatory waiting period between stopping Eliquis and starting aspirin. Start aspirin immediately unless you're in a peri-procedural context where hemostasis concerns dictate timing.

Related Questions

Should a patient with chest pain who has already taken 100 mg of aspirin and is on apixaban receive an additional aspirin loading dose?
In a patient with no comorbidities who was switched from subcutaneous antiplatelet therapy plus aspirin to apixaban 5 mg twice daily, and now has rectal/anal pain only on straining or during urination without abdominal distension, how should this pain be managed?
Should low-dose aspirin (81 mg) be discontinued prior to dental extraction in a patient taking apixaban (Eliquis)?
Is it safe to start delayed-release 81 mg aspirin in a patient already taking apixaban 5 mg twice daily?
After an amputation surgery, how many days can I safely discontinue Eliquis (apixaban) for venous thromboembolism prophylaxis?
What are the recommended levonadifloxacin dosing regimens for adults with different infections (e.g., acute bacterial skin‑structure infections, uncomplicated skin infections, pneumonia, prostatitis, urinary‑tract infection) and how should the dose be adjusted in renal impairment?
How does alcohol affect methadone?
What should I do if I am vomiting yellow bile while taking methadone and have consumed alcohol?
Can a woman who had a hysterectomy for endometriosis but retained only one ovary develop recurrent endometriosis two years after the surgery?
What is the recommended dosing regimen for pembrolizumab, albumin‑bound paclitaxel (nab‑paclitaxel), and carboplatin in patients with squamous non‑small cell lung cancer?
Is amitriptyline appropriate for treating restless‑leg syndrome in a 49‑year‑old woman with seizures who is taking levetiracetam (Keppra), vitamin D, and hydroxyzine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.